Cargando...
Antileukemia T-cell responses in CLL – We don't need no aberration
Effective antigen-specific cancer immunotherapy requires exact knowledge of tumor-associated epitopes that can act as rejection antigens. Although the current paradigm views mutation-derived neoantigens as the most promising targets, we have recently demonstrated that leukemia-specific T-cell respon...
Gardado en:
| Publicado en: | Oncoimmunology |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485708/ https://ncbi.nlm.nih.gov/pubmed/26140235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1011527 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|